Who should not take Cerebrolysin?
Documented caution flags for Cerebrolysin include porcine allergy and active seizure disorder (theoretical, monitored in trials). This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Cerebrolysin is limited.
Documented caution flags for Cerebrolysin
- Porcine allergy
- Active seizure disorder (theoretical, monitored in trials)
- Pregnancy / nursing
Reported side effects to weigh
- Injection-site irritation (volume is large for IM)
- Mild fatigue early
- Rare: allergic reaction (porcine origin)
References
- Cerebrolysin in acute ischemic stroke, Cochrane review — Ziganshina LE et al., Cochrane Database Syst Rev, 2020
- Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study — Khasanova DR et al., BMC Neurology, 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Cerebrolysin
Last updated 2026-06-15.